We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$497M
AUM Growth
-$1.15M
(-0.23%)
Cap. Flow
-$10.6M
Cap. Flow
% of AUM
-2.12%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
406
New
23
Increased
155
Reduced
91
Closed
79
Avg Time Held
1.9
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$6.71M |
| 2 |
TJX Companies
TJX
|
+$2.75M |
| 3 |
SLB Ltd
SLB
|
+$2.72M |
| 4 |
AGN
Allergan plc
AGN
|
+$2.72M |
| 5 |
Air Products & Chemicals
APD
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$9.54M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$5.83M |
| 3 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$4.56M |
| 4 |
Phillips 66
PSX
|
+$2.89M |
| 5 |
Biogen
BIIB
|
+$2.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.81% |
| 2 | Healthcare | 5.65% |
| 3 | Financials | 5.07% |
| 4 | Consumer Discretionary | 4.4% |
| 5 | Industrials | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Tyler Technologies
TYL
$14.6B
| $186K | 0.04% |
1,115
| – | – |
2016 Q1
1 quarter
|
|
177
Chevron
CVX
$439B
| $184K | 0.04% |
1,754
-740
| -30% | -$74.4K |
2013 Q2
12 quarters
|
|
178
Novartis
NVS
$287B
| $172K | 0.03% |
2,326
+78
| +3% | +$5.39K |
2014 Q4
6 quarters
|
|
179
Manhattan Associates
MANH
$12.9B
| $171K | 0.03% |
+2,660
| New | +$166K |
2016 Q2
0 quarters
|
|
180
Abbott
ABT
$181B
| $159K | 0.03% |
4,033
| – | – |
2013 Q2
12 quarters
|
|
181
UnitedHealth
UNH
$359B
| $157K | 0.03% |
1,113
-99
| -8% | -$13.2K |
2013 Q2
12 quarters
|
|
182
iShares US Real Estate ETF
IYR
$4.16B
| $147K | 0.03% |
1,790
-100
| -5% | -$7.84K |
2013 Q2
12 quarters
|
|
183
Carnival Corporation Ltd
CCL
$35.2B
| $147K | 0.03% |
3,316
+118
| +4% | +$5.79K |
2013 Q2
12 quarters
|
|
184
Procter & Gamble
PG
$368B
| $145K | 0.03% |
1,713
-145
| -8% | -$11.9K |
2013 Q2
12 quarters
|
|
185
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.2B
| $143K | 0.03% |
+3,268
| New | +$142K |
2016 Q2
0 quarters
|
|
186
Balchem Corp
BCPC
$5.42B
| $143K | 0.03% |
+2,395
| New | +$146K |
2016 Q2
0 quarters
|
|
187
Goldman Sachs
GS
$256B
| $136K | 0.03% |
918
| – | – |
2013 Q2
12 quarters
|
|
188
DuPont de Nemours
DD
$17.7B
| $127K | 0.03% |
1,010
+208
| +26% | +$27.4K |
2013 Q4
10 quarters
|
|
189
Union Pacific
UNP
$171B
| $126K | 0.03% |
1,440
| – | – |
2013 Q2
12 quarters
|
|
190
Accendra Health
ACH
$17.9M
| $125K | 0.03% |
3,343
-1,408
| -30% | -$52.9K |
2013 Q2
12 quarters
|
|
|
LNKD
191
DELISTED
LinkedIn Corporation
LNKD
| $124K | 0.02% |
655
+58
| +10% | +$8.04K |
2016 Q1
1 quarter
|
|
192
Emerson Electric
EMR
$89.4B
| $122K | 0.02% |
2,336
-90
| -4% | -$4.78K |
2013 Q2
12 quarters
|
|
193
Kimberly-Clark
KMB
$34.8B
| $120K | 0.02% |
870
-40
| -4% | -$5.24K |
2013 Q4
10 quarters
|
|
194
Bio-Rad Laboratories Class A
BIO
$9.49B
| $117K | 0.02% |
821
| – | – |
2013 Q3
11 quarters
|
|
|
AGU
195
DELISTED
Agrium
AGU
| $116K | 0.02% |
1,283
| – | – |
2013 Q4
10 quarters
|
|
196
RPM International
RPM
$12.7B
| $114K | 0.02% |
2,280
| – | – |
2014 Q1
9 quarters
|
|
197
Aflac
AFL
$59.6B
| $111K | 0.02% |
3,070
-40
| -1% | -$1.37K |
2013 Q2
12 quarters
|
|
198
Teck Resources
TECK
$31.8B
| $110K | 0.02% |
8,320
| – | – |
2013 Q4
10 quarters
|
|
199
Crown Castle
CCI
$34.7B
| $107K | 0.02% |
1,057
+7
| +0.7% | +$635 |
2015 Q1
5 quarters
|
|
200
Avnet
AVT
$7.47B
| $107K | 0.02% |
2,631
| – | – |
2013 Q2
12 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2016 Portfolio in Review
As of Q2 2016, Capital Analysts LLC held 406 positions worth $497M, down 0.23% from $498M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Capital Analysts LLC's Q2 2016 filing shows 23 new, 155 increased, 91 reduced and 79 closed positions. Its largest new stake was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF: 18,181 shares worth $892K. The largest sale was iShares Russell 3000 ETF, an estimated $9.54M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, up from 64% a quarter earlier, followed by Healthcare and Financials.
- Capital Analysts LLC's largest Q2 2016 buy was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF: 18,181 shares worth $892K.
- Capital Analysts LLC added most to SPDR Gold Trust in Q2 2016, an estimated $6.71M increase.
- Capital Analysts LLC's biggest Q2 2016 reduction was iShares Russell 3000 ETF, cutting an estimated $9.54M.
- Capital Analysts LLC fully exited State Street SPDR S&P 500 ETF Trust in Q2 2016, selling an estimated $2.39M.
- Capital Analysts LLC's ten largest holdings make up 40% of its $497M portfolio in Q2 2016.
- Capital Analysts LLC opened 23 new positions and closed 79 in Q2 2016.
- Capital Analysts LLC's portfolio value fell 0.23% quarter-over-quarter to $497M.
Based on Capital Analysts LLC's 13F filing for Q2 2016, filed 14 Jul 2016.